XML 26 R8.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating activities:      
Net income (loss) $ (2,406) $ 456 $ (4,099)
Adjustments to reconcile net income (loss) to net cash provided by operations:      
Impairment of goodwill, long-lived assets and assets held for sale 2,447 584 6,546
Depreciation and amortization 1,308 1,330 1,557
Net change in operating assets and liabilities 1,257 (1,701) (2,188)
Deferred income taxes — net and uncertain tax positions (1,059) (120) (696)
Stock-based compensation 124 119 129
Other items (91) 16 100
Research and development in process 0 10 80
Net loss (gain) from investments and from sale of business and long lived assets 10 104 (213)
Net cash provided by (used in) operating activities 1,590 798 1,216
Investing activities:      
Beneficial interest collected in exchange for securitized trade receivables 1,140 1,648 1,405
Proceeds from sale of business and long lived assets 68 311 67
Purchases of property, plant and equipment (548) (562) (578)
Purchases of investments and other assets (1) (47) (55)
Proceeds from sale of investments 4 172 12
Other investing activities 0 1 12
Acquisitions of businesses, net of cash acquired (7) 0 0
Net cash provided by (used in) investing activities 656 1,523 863
Financing activities:      
Repayment of senior notes and loans and other long-term liabilities (1,369) (6,649) (1,871)
Proceeds from senior notes, net of issuance costs 0 4,974 0
Proceeds from short term debt 0 700 550
Repayment of short term debt 0 (700) (559)
Redemption of convertible debentures 0 (491) 0
Other financing activities (118) (6) (5)
Net cash provided by (used in) financing activities (1,487) (2,172) (1,885)
Translation adjustment on cash and cash equivalents (123) (128) 8
Net change in cash, cash equivalents and restricted cash 636 21 202
Balance of cash, cash equivalents and restricted cash at beginning of year 2,198 2,177 1,975
Balance of cash, cash equivalents and restricted cash at end of year 2,834 2,198 2,177
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheet:      
Cash and cash equivalents 2,801 2,165 2,177
Restricted cash included in other current assets 33 33 0
Total cash, cash equivalents and restricted cash shown in the statement of cash flows 2,834 2,198 2,177
Non-cash financing and investing activities:      
Beneficial interest obtained in exchange for securitized trade receivables 1,189 1,635 1,397
Cash paid during the year for:      
Interest 948 913 846
Income taxes, net of refunds 543 495 709
Net change in operating assets and liabilities:      
Other current assets (828) (2,271) (1,473)
Trade payables, accrued expenses, employee-related obligations and other liabilities 1,914 764 (463)
Trade receivables net of sales reserves and allowances 334 (574) (293)
Inventories (163) 380 41
Net Change In Items Comprising Supplemental Disclosure Of Cash Flow Information $ 1,257 $ (1,701) $ (2,188)